About Niall O'Donnell
Niall O'Donnell is a director at Allotera Therapeutics.
Experience
This experience comes from Niall O'Donnell's profile and from SEC filings. For roles taken from filings, the years are when the filings name Niall O'Donnell in the role, so the role may have started earlier or lasted longer.
AS
American Thoracic Society Current
Co-Chair of Respiratory Innovation Summit
2026 – Present
UM
University of California, Davis - Graduate School of Management Current
Member of the Board of Advisors
2024 – Present
RP
RiverVest Venture Partners Current
Managing Director
2006 – Present
Allotera Therapeutics, Inc.
Director
2025 – 2026 · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
LI
Lumena Pharmaceuticals Inc.
Interim Chief Medical Officer
2011 – 2013
JP
J&J PRD
Post Doctoral Fellow and Researcher
2002 – 2006
Key Colleagues at Startups
The people Niall O'Donnell works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
KL
Kevin Li
Director
NM
Natalie Mount
Director
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
PK
Peter Kiener
Chair
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Bali Muralidhar
Director